Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Raymond James Upgrades Toll Brothers to Outperform

Raymond James analyst Buck Horne upgrades Toll Brothers (NYSE:TOL) from Market Perform to Outperform.
byBenzinga Newsdesk
January 9, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Raymond James analyst Buck Horne upgrades Toll Brothers (NYSE:TOL) from Market Perform to Outperform.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Zivo Bioscience Said USDA Letter Affirmed Agency Has Claimed Jurisdiction for Reviewing the Company’s Novel Immune-Modulating Biologic for Treating Coccidiosis in Broiler Chickens

By Charles Gross
August 23, 7:38 AM
In August 2022, Zivo Bioscience, Inc. (the "Company") announced receipt of a letter from the U.S. Department of Agriculture's (USDA) Center for Veterinary Biologics (CVB) affirming that the agency has claimed jurisdiction for reviewing the Company's novel immune-modulating biologic for treating coccidiosis in broiler chickens.

ZIVO

Read More

Aurinia Pharmaceuticals Announced Departure of Executive Vice President, Research and Chief Medical Officer

By Charles Gross
October 21, 6:16 AM
On October 17, 2022, Aurinia Pharmaceuticals Inc. and Robert Huizinga, PhD RN, CNeph(C), our Executive Vice President, Research and Neil Solomons, M.D., our ChiefMedical Officer, mutually agreed that Dr. Huizinga and Dr. Solomons would cease their employment with Aurinia, each effective October 31, 2022.We expect to enter into separation agreements with Dr. Huizinga and Dr.

AUPH